Basics Candel Therapeutics, Inc. Common Stock IPO Date: July 27, 2021 Sector: Healthcare Industry: Biotech Market Cap: $313.14M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 5.08% Avg Daily Range (30 D): $0.18 | 3.23% Avg Daily Range (90 D): $0.22 | 3.77% Institutional Daily Volume Avg Daily Volume: .7M Avg Daily Volume (30 D): .88M Avg Daily Volume (90 D): .89M Trade Size Avg Trade Size (Sh.): 151 Avg Trade Size (Sh.) (30 D): 141 Avg Trade Size (Sh.) (90 D): 133 Institutional Trades Total Inst.Trades: 103 Avg Inst. Trade: $1.44M Avg Inst. Trade (30 D): $1.73M Avg Inst. Trade (90 D): $1.72M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.15M Avg Closing Trade (30 D): $3.16M Avg Closing Trade (90 D): $4.14M Avg Closing Volume: 311.83K     News Apr 1, 2025 @ 12:01 PM Candel Therapeutics Announces Publication of Phase... Source: N/A Mar 18, 2025 @ 12:00 PM Candel Therapeutics Appoints Renowned Pancreatic C... Source: N/A Dec 12, 2024 @ 9:51 PM Candel Therapeutics Announces $80 Million Proposed... Source: N/A Sep 4, 2024 @ 12:00 PM Milestone Pharmaceuticals Appoints Industry Vetera... Source: N/A Jul 19, 2024 @ 12:41 PM Candel Therapeutics executive sells over $63k in c... Source: Investing.Com Financials   TTM Q1 2025 Q3 2024 Basic EPS $.15 $-.33 Diluted EPS $.13 $-.33 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ 7.38M $ -10.65M Operating Income / Loss $ $ -8.13M $ -8.76M Cost of Revenue $ $ $ Net Cash Flow $ $ -10.49M $ -4.9M PE Ratio